PDCD1LG2 and osteosarcoma: A previous study suggested that PD-L2 knockdown inhibited osteosarcoma pulmonary metastasis by the RhoA-ROCK-LIMK2 pathway (11); thus, we further investigated the effect of apatinib on the RhoA-ROCK-LIMK2 pathway.